Fernando de Mora

1.2k total citations
69 papers, 848 citations indexed

About

Fernando de Mora is a scholar working on Immunology, Physiology and Immunology and Allergy. According to data from OpenAlex, Fernando de Mora has authored 69 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 24 papers in Physiology and 17 papers in Immunology and Allergy. Recurrent topics in Fernando de Mora's work include Asthma and respiratory diseases (23 papers), Mast cells and histamine (22 papers) and Allergic Rhinitis and Sensitization (12 papers). Fernando de Mora is often cited by papers focused on Asthma and respiratory diseases (23 papers), Mast cells and histamine (22 papers) and Allergic Rhinitis and Sensitization (12 papers). Fernando de Mora collaborates with scholars based in Spain, Mexico and United States. Fernando de Mora's co-authors include Rosa Torres, César Picado, Anna Puigdemont, Lluís Ferrer, Pilar Brazís, G. García, Alberto Marco, M. Arboix, Bart C.J.M. Fauser and Patri Vergara and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Fernando de Mora

61 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando de Mora Spain 19 414 326 213 144 111 69 848
J. A. M. Raaijmakers Netherlands 17 417 1.0× 409 1.3× 167 0.8× 318 2.2× 192 1.7× 44 1.3k
R. Buquicchio Italy 13 161 0.4× 214 0.7× 202 0.9× 93 0.6× 45 0.4× 40 746
Stéphane Kirkesseli United States 11 354 0.9× 851 2.6× 335 1.6× 92 0.6× 466 4.2× 16 1.3k
Toshihiko Kaise Japan 16 143 0.3× 254 0.8× 144 0.7× 131 0.9× 200 1.8× 47 777
Öner Özdemır Türkiye 12 146 0.4× 107 0.3× 124 0.6× 158 1.1× 51 0.5× 154 715
Norihiro Saito Japan 15 175 0.4× 314 1.0× 81 0.4× 121 0.8× 148 1.3× 56 642
P. Stahl Skov Denmark 20 307 0.7× 387 1.2× 625 2.9× 111 0.8× 100 0.9× 55 1.2k
Di Yan United States 21 558 1.3× 159 0.5× 99 0.5× 224 1.6× 27 0.2× 37 1.4k
P Godard France 17 151 0.4× 681 2.1× 285 1.3× 105 0.7× 482 4.3× 66 1.1k

Countries citing papers authored by Fernando de Mora

Since Specialization
Citations

This map shows the geographic impact of Fernando de Mora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando de Mora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando de Mora more than expected).

Fields of papers citing papers by Fernando de Mora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando de Mora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando de Mora. The network helps show where Fernando de Mora may publish in the future.

Co-authorship network of co-authors of Fernando de Mora

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando de Mora. A scholar is included among the top collaborators of Fernando de Mora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando de Mora. Fernando de Mora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mora, Fernando de, et al.. (2025). Arrival of biosimilars in respiratory medicine: towards improved access to biologics for patients. The Lancet Respiratory Medicine. 13(7). 574–576. 1 indexed citations
2.
Marras, Carlos, Daniel Ginard, J.M. Carrascosa, et al.. (2024). An Educational Digital Tool to Improve the Implementation of Switching to a Biosimilar (Rapid Switch Trainer): Tool Development and Validation Study. JMIR Formative Research. 8. e56553–e56553.
3.
Mora, Fernando de & Colin M. Howles. (2022). Overlapping biosimilar and originator follitropin alfa preparations: How much closer can they get?. Drug Discovery Today. 27(8). 2071–2075. 2 indexed citations
4.
Mora, Fernando de. (2019). Biosimilars: A Value Proposition. BioDrugs. 33(4). 353–356. 26 indexed citations
5.
Mora, Fernando de, et al.. (2016). Rethinking banking: How to fit bank business models to regulatory constraints. Journal of risk management in financial institutions. 9(4). 351–351. 1 indexed citations
6.
Mora, Fernando de, et al.. (2015). FACTORES EDÁFICOS QUE INFLUYEN EN EL CRECIMIENTO DE \nVochysia guatemalensis EN LA REGIÓN HUETAR NORTE DE COSTA RICA. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Torres, Rosa, César Picado, & Fernando de Mora. (2014). The PGE2–EP2–mast cell axis: An antiasthma mechanism. Molecular Immunology. 63(1). 61–68. 34 indexed citations
9.
Rodríguez, Beatriz L., et al.. (2008). Adaptación individual y depresión en una muestra de pacientes oncológicos. SHILAP Revista de lepidopterología. 5 indexed citations
10.
Torres, Rosa, Jordi Roca‐Ferrer, Laura Pujols, et al.. (2008). An intranasal selective antisense oligonucleotide impairs lung cyclooxygenase-2 production and improves inflammation, but worsens airway function, in house dust mite sensitive mice. Respiratory Research. 9(1). 72–72. 11 indexed citations
11.
Torres, Rosa, et al.. (2006). Sensitization of Naive Beagles by Intradermal Injection of an Ascaris Antigen: Induction of a Model of Skin Allergy. Immunopharmacology and Immunotoxicology. 28(4). 697–702. 3 indexed citations
12.
Mora, Fernando de, Cristian de la Fuente, H. Gatto, et al.. (2006). Evaluation of the expression of P-selectin, ICAM-1, and TNF-alpha in bacteria-free lesional skin of atopic dogs with low-to-mild inflammation. Veterinary Immunology and Immunopathology. 115(3-4). 223–229. 8 indexed citations
13.
Mora, Fernando de, et al.. (2006). Estimación del volumen comercial por producto para rodales de teca en el Pacífico de Costa Rica. Agronomía Costarricense. 2 indexed citations
15.
Torres, Rosa, et al.. (2002). Evaluation of cell-surface IgE receptors on the canine mastocytoma cell line C2 maintained in continuous culture. American Journal of Veterinary Research. 63(5). 763–766. 15 indexed citations
16.
Torres, Rosa, et al.. (2002). Antinerve Growth Factor Treatment Prevents Intestinal Dysmotility in Trichinella spiralis-Infected Rats. Journal of Pharmacology and Experimental Therapeutics. 302(2). 659–665. 25 indexed citations
17.
18.
Pérez, Yolanda, Anna Puigdemont, Carles Cristòfol, Fernando de Mora, & M. Arboix. (1994). Comparison of theophylline pharmacokinetics in yearling and 4‐year‐old horses. Journal of Veterinary Pharmacology and Therapeutics. 17(6). 473–476. 4 indexed citations
19.
Puigdemont, Anna, Raimón Guitart, Fernando de Mora, & M. Arboix. (1991). Prediction of the Disposition of Propafenone in Humans and Dogs from Pharmacokinetic Parameters in Other Animal Species. Journal of Pharmaceutical Sciences. 80(12). 1106–1109. 14 indexed citations
20.
Puigdemont, Anna, et al.. (1987). Pharmacokinetics of propafenone in the dog after single‐dose intravenous administration. Journal of Veterinary Pharmacology and Therapeutics. 10(4). 351–353. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026